Amarin Analysts React To Vascepa Patent Loss, See Small Chance Of Overturning JudgmentBenzinga • 03/31/20
Amarin's stock plummets on heavy volume after court rules in favor of makers of generic VascepaMarket Watch • 03/31/20
Amarin Highlights VASCEPA® (Icosapent Ethyl)-Related Data Presented at American College of Cardiology’s Annual Scientific Session Together With World Congress of Cardiology (ACC.20/WCC)GlobeNewsWire • 03/31/20
Do Options Traders Know Something About Amarin (AMRN) Stock We Don't?Zacks Investment Research • 03/25/20